X. Sun, M. Minohara, H. Kikuchi, T. Ishizu, M. Tanaka and H. Piao, et al., “The Selective Rho-Kinase Inhibitor Fasudil Is Protective and Therapeutic in Experimental Autoimmune Encephalomyelitis,” Journal of Neuroimmunology, Vol. 180, 2006, pp. 126-134. http://dx.doi.org/10.1016/j.jneuroim.2006.06.027

has been cited by the following article:

• TITLE: The Phenotypic Conversion of Macrophage Detected by FACS in EAE Mice Treated with or without Fasudil

  AUTHORS: Chunyun Liu, Yong Xie, Yanhua Li, Jiezhong Yu, Ling Feng, Shaowei Hou, Haifei Zhang, Cungen Ma, Baoguo Xiao

  KEYWORDS: Experiment Autoimmune Excephomeylitis; Fasudil; Flow Cytometry; Macrophage

  JOURNAL NAME: Engineering, Vol.5 No.10B, December 18, 2013

  ABSTRACT: We studied the changes of macrophage populations in splenic mononuclear cells of experimental autoimmune ence-phalomyelitis (EAE) mice treated with or without Fasudil. Phenotypic analysis using flow cytometry showed that the levels of TLR4, CD11c and CD40 which represent the type 1 macrophage, were depressed in Fasudil-treated mice. Incontrast, it was observed the expressions of CD200 and CD14 which typify the type 2 macrophage were elevated in Fasudil-treated mice as compared to EAE mice. And we also found that Fasudil at dose of 40 mg/kg alleviated the se-verity of symptom in EAE mice. Based on the evidence that M1 macrophages are neurotoxic and M2 macrophages promote a regenerative growth, indicating that polarization and shifting of macrophages into M2 cells may also play key roles in treatment of EAE.